Abrahm, JL. Skin problems. In A Physician’s Guide to Pain and Symptom Management in Cancer Patients. Baltimore: John Hopkins University Press; 2014:468-469
Bensadoun RJ, Humbert P. Krutman J, Luger T, Triller R, Rougier A, Seite S, Dreno B. Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel. Cancer Management and Research. 2013; 5:401-408.
Brant JM, Stringer LH. Skin & nail alterations. In Brown CG, ed. A Guide to Oncology Symptom Management. 2nd ed. Pittsburgh, PA: Oncology Nursing Society; 2015:599-619
Cancer.Net. Skin conditions. 2018. Accessed at https://www.cancer.net/coping-with-cancer/physical-emotional-and-social-effects-cancer/managing-physical-side-effects/skin-conditions on September 18, 2019.
Mathews NH, Moustafa F, Kaskas NM, Robinson-Bostom L, Pappas-Taffer L. Dermatologic toxicities of anticancer therapy. In Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:628-630
National Cancer Institute (NIH). Skin and nail changes during cancer treatment. 2019. Accessed at https://www.cancer.gov/about-cancer/treatment/side-effects/skin-nail-changes on September 19, 2019.
Williams LA, Ginex PK, Ebanks Jr. GL, et al. ONS Guidelines for Cancer Treatment-Related Skin Toxicity. Oncology Nursing Forum. 2020; 47(5).